Insider Trading & Ownership - Rawcliffe Adrian

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rawcliffe Adrian
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2025-01-17
Sale		 2025-01-17
9:15 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 30,601 $0.5808 $17,773 44,327
(Direct)		 View
2025-01-13
Sale		 2025-01-15
4:19 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 59,569 $0.5815 $34,639 41,582
(Direct)		 View
2024-01-16
Sale		 2024-01-17
5:31 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 39,384 $0.70064 $27,594 44,848
(Direct)		 View
2024-01-11
Sale		 2024-01-12
5:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 29,202 $0.84698 $24,734 26,388
(Direct)		 View
2023-09-01
Sale		 2023-09-01
7:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,403 $0.78 $1,874 3,449
(Direct)		 View
2023-06-27
Sale		 2023-06-27
9:15 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,333 $0.92 $2,146 3,519
(Direct)		 View
2023-01-17
Sale		 2023-01-17
9:15 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 10,057 $1.858 $18,686 13,351
(Direct)		 View
2023-01-11
Sale		 2023-01-12
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 31,805 $1.7227 $54,791 24,882
(Direct)		 View
2023-01-04
Sale		 2023-01-04
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 5,073 $1.694 $8,594 6,631
(Direct)		 View
2022-09-01
Sale		 2022-09-01
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,536 $1.9689 $4,993 3,316
(Direct)		 View
2022-06-27
Sale		 2022-06-27
9:01 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,562 $1.63 $4,176 3,290
(Direct)		 View
2022-01-18
Sale		 2022-01-18
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 11,096 $3.1918 $35,416 12,312
(Direct)		 View
2022-01-11
Sale		 2022-01-13
9:01 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 17,408 $3.5545 $61,877 3,356
(Direct)		 View
2022-01-04
Sale		 2022-01-05
9:04 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 5,532 $4.0642 $22,483 6,172
(Direct)		 View
2021-09-01
Sale		 2021-09-01
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,782 $5.195 $14,452 3,070
(Direct)		 View
2021-06-28
Sale		 2021-06-28
9:01 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,794 $4.37 $12,210 3,058
(Direct)		 View
2021-01-19
Sale		 2021-01-19
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 9,879 $5.6695 $56,009 13,529
(Direct)		 View
2021-01-12
Sale		 2021-01-12
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,707 $6.1522 $16,654 3,695
(Direct)		 View
2021-01-04
Sale		 2021-01-05
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 4,967 $5.3279 $26,464 6,737
(Direct)		 View
2020-09-01
Sale		 2020-09-02
9:00 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,776 $8.5149 $23,637 3,076
(Direct)		 View
2020-08-03
Sale		 2020-08-04
9:01 pm		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 2,788 $9.25 $25,789 3,064
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2025-02-20
Option Award		 2025-02-20
5:30 pm		 N/A
2035-02-20		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 8,572,080 $0 8,572,080
(Direct)		 View
2024-08-12
Option Award		 2024-08-14
6:00 pm		 N/A
2029-08-12		 Wave Life Sciences Ltd. WVE Rawcliffe Adrian
Director		 48,345 $0 48,345
(Direct)		 View
2024-01-15
Option Award		 2024-01-17
5:00 pm		 N/A
2034-01-15		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 9,329,568 $0 9,329,568
(Direct)		 View
2023-08-07
Option Award		 2023-08-09
8:00 pm		 N/A
2028-08-07		 Wave Life Sciences Ltd. WVE Rawcliffe Adrian
Director		 45,000 $0 45,000
(Direct)		 View
2023-01-17
Option Award		 2023-01-17
9:01 pm		 N/A
2033-01-17		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 6,488,496 $0 6,488,496
(Direct)		 View
2022-08-15
Option Award		 2022-08-17
8:01 pm		 N/A
2027-08-15		 Wave Life Sciences Ltd. WVE Rawcliffe Adrian
Director		 21,000 $0 21,000
(Direct)		 View
2022-01-12
Option Award		 2022-01-13
9:00 pm		 N/A
2032-01-12		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 5,737,704 $0 5,737,704
(Direct)		 View
2021-08-16
Option Award		 2021-08-18
6:10 pm		 N/A
2026-08-16		 Wave Life Sciences Ltd. WVE Rawcliffe Adrian
Director		 42,000 $0 42,000
(Direct)		 View
2021-01-11
Option Award		 2021-01-11
9:02 pm		 N/A
2031-01-11		 Adaptimmune Therapeutics PLC ADAP Rawcliffe Adrian
Chief Executive Officer		 3,988,560 $0 3,988,560
(Direct)		 View
2020-08-18
Option Award		 2020-08-20
6:32 pm		 N/A
2025-08-18		 Wave Life Sciences Ltd. WVE Rawcliffe Adrian
Director		 10,500 $0 10,500
(Direct)		 View